Efficacy and safety of daclatasvir and asunaprevir for hepatitis C virus genotype 1b infection

BACKGROUND/AIMS: The treatment strategy for hepatitis C virus (HCV) has been changing rapidly since the introduction of direct-acting antivirals such as daclatasvir (DCV) and asunaprevir (ASV). We evaluated the efficacy and safety of DCV and ASV for HCV in real-life practice. METHODS: Patients were...

Descripción completa

Detalles Bibliográficos
Autores principales: Nam, Hee Chul, Lee, Hae Lim, Yang, Hyun, Song, Myeong Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946403/
https://www.ncbi.nlm.nih.gov/pubmed/27377910
http://dx.doi.org/10.3350/cmh.2016.0020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946403/
https://www.ncbi.nlm.nih.gov/pubmed/27377910
http://dx.doi.org/10.3350/cmh.2016.0020

Ejemplares similares